Buy, Hold, or Sell: Wall Street Fears Tech Compression, but This AI Storage Monster Has a Hidden Weapon

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Seagate (STX) smashed Q3 estimates with $4.10 EPS versus a $3.51 consensus, generating $953 million in free cash flow while locking nearline production through mid-2026.

  • A trailing P/E of 89 and beta of 2.08 leave STX exposed to rapid multiple compression if tighter Fed policy hits high-multiple tech names.

  • A macro-driven pullback to $850 would reset the forward P/E into the high twenties, with locked capacity through 2027 providing a fundamental floor.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Seagate Technology didn't make the cut. Grab the names FREE today.

Buy, Hold, or Sell: Wall Street Fears Tech Compression, but This AI Storage Monster Has a Hidden Weapon

© 24/7 Wall St.

At $1,031.34, Seagate Technology (NASDAQ:STX | STX Price Prediction) looks fully valued, with a more attractive risk/reward profile only emerging on a macro-driven pullback toward $850. The stock just hit a fresh 52-week high on analyst target hikes, even as Wall Street braces for tighter Fed policy that could compress high-multiple tech names.

Seagate leads in nearline hard disk drives, the storage that hyperscale data centers buy by the exabyte. The company’s HAMR-based Mozaic platform is now qualified with five of the world’s largest cloud customers, and management says nearline production is largely spoken for through mid-calendar 2026.

Shares are up 697.03% over the past year and 21.91% in the past week alone. The question is whether the next leg up is already priced in.

The Bull Case: A Capacity-Constrained AI Infrastructure Play

Bulls argue Seagate has decoupled from the traditional HDD cycle. Q3 FY2026 delivered $4.10 in adjusted EPS against a $3.51 consensus, on revenue of $3.11 billion that grew 44.07% year over year. Non-GAAP gross margin hit 47.0%, free cash flow reached $953 million, and the company retired $641 million in debt in a single quarter.

Q4 guidance calls for $3.45 billion in revenue and $5.00 in EPS at the midpoint. Morgan Stanley raised its target to $1,035 from $767 and named STX a Top Pick, citing HDD shortages through 2028. Citi went to $1,150.

The Bear Case: A Cyclical Trading Like a Software Compounder

Bears see a parabolic chart fueled by a one-week melt-up. Trailing P/E sits at 89, price-to-sales at 19, and beta at 2.08. With Fed Chair Kevin Warsh signaling a stricter, inflation-fighting stance, high-multiple tech sits in the crosshairs of multiple compression.

Insiders are selling. The CFO sold 903 shares for roughly $795,029, and the CEO unloaded $1.56 million after RSU vesting. The HDD industry remains structurally cyclical, and Exchangeable Senior Notes due 2028 become dilutive whenever shares trade above roughly $108.

The Hold Case: Right Company, Wrong Entry

The business is firing on every cylinder, yet the stock just printed a 52-week high of $1,032.52. Chasing it here means buying a cyclical at multiples that assume zero air pockets in the AI capex cycle. Selling means abandoning a name whose build-to-order capacity is already locked through 2027.

What to watch: Q4 FY2026 report against the $5.00 EPS bar, HAMR exabyte crossover in the back half of calendar 2026, and any Fed-driven volatility that resets the multiple.

What the Numbers Actually Say

Shares trade at $1,031.34 against a consensus 12-month target of $885.91, implying modest downside even after upgrades. Forward P/E sits at 38.

Of 24 analysts tracked, the breakdown is 4 Strong Buy, 16 Buy, 3 Hold, 0 Sell, and 1 Strong Sell. Targets are guideposts subject to revision, especially after a one-week move of this size.

Performance: 275.17% year to date and 697.03% over twelve months, against a low-single-digit gain for the S&P 500 over the same stretch.

The Verdict: Wait for the Macro to Hand You a Better Price

At $1,031.34, Seagate Technology looks fully valued at current levels.

The franchise is concrete. Locked-in nearline allocation, $953 million in quarterly free cash flow, and a Mozaic roadmap stretching to 50TB drives all support the bull thesis. The problem is the entry. Buying at a fresh 52-week high, with consensus targets sitting below the print and an RSI flagging overbought conditions, demands a multiple that any Warsh-led tightening cycle could pressure quickly.

A macro-driven retracement to the $850 zone would re-rate the forward P/E into the high twenties on the FY2027 trajectory, with structurally allocated capacity providing a floor. A Sell requires either a HAMR qualification slip or hyperscaler capex digestion, neither of which the data currently shows.

Existing holders have a fundamentally sound business behind the position, while new entries may find a more compelling setup after the next inflation reading or Fed surprise resets the multiple.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SMCI Vol: 106,611,715
ON Vol: 7,016,730
GLW Vol: 12,418,966
ABBV Vol: 6,217,022
GNRC Vol: 815,842

Top Losing Stocks

CTRA Vol: 73,319,495
ACN Vol: 20,878,518
PLTR Vol: 42,794,427
MRNA Vol: 6,341,555
GEN Vol: 4,037,085